131 related articles for article (PubMed ID: 16015684)
1. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.
Chang ML; Yeh CT; Chang PY; Chen JC
World J Gastroenterol; 2005 Jul; 11(27):4167-72. PubMed ID: 16015684
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation.
Bahçecioğlu IH; Yalniz M; Ataseven H; Bülbüller N; Keçeci M; Demirdağ K; Ozercan I; Ustündağ B
Cell Biochem Funct; 2004; 22(6):359-63. PubMed ID: 15386444
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
Geerts AM; Vanheule E; Praet M; Van Vlierberghe H; De Vos M; Colle I
Int J Exp Pathol; 2008 Aug; 89(4):251-63. PubMed ID: 18715470
[TBL] [Abstract][Full Text] [Related]
4. A contradictory role of A1 adenosine receptor in carbon tetrachloride- and bile duct ligation-induced liver fibrosis in mice.
Yang P; Han Z; Chen P; Zhu L; Wang S; Hua Z; Zhang J
J Pharmacol Exp Ther; 2010 Mar; 332(3):747-54. PubMed ID: 20007753
[TBL] [Abstract][Full Text] [Related]
5. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis.
Vanheule E; Geerts AM; Van Huysse J; Schelfhout D; Praet M; Van Vlierberghe H; De Vos M; Colle I
Int J Exp Pathol; 2008 Dec; 89(6):419-32. PubMed ID: 19134051
[TBL] [Abstract][Full Text] [Related]
6. Ketoprofen glucuronidation and bile excretion in carbon tetrachloride and alpha-naphthylisothiocyanate induced hepatic injury rats.
Zhao Y; Zhai D; Chen X; Yang J; Song X; He H; Yu Q; Xing Y
Toxicology; 2007 Feb; 230(2-3):145-50. PubMed ID: 17184895
[TBL] [Abstract][Full Text] [Related]
7. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection.
Marques TG; Chaib E; da Fonseca JH; Lourenço AC; Silva FD; Ribeiro MA; Galvão FH; D'Albuquerque LA
Acta Cir Bras; 2012 Aug; 27(8):589-94. PubMed ID: 22850713
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
10. A microcholangiographic study of liver disease models in rats.
Lichtman SN; Wang J; Clark RL
Acad Radiol; 1995 Jun; 2(6):515-21. PubMed ID: 9419599
[TBL] [Abstract][Full Text] [Related]
11. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
12. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
13. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
14. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
15. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
16. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
[TBL] [Abstract][Full Text] [Related]
18. Modeling liver fibrosis in rodents.
Constandinou C; Henderson N; Iredale JP
Methods Mol Med; 2005; 117():237-50. PubMed ID: 16118456
[TBL] [Abstract][Full Text] [Related]
19. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
20. Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.
Dondorf F; Fahrner R; Ardelt M; Patsenker E; Stickel F; Dahmen U; Settmacher U; Rauchfuß F
World J Gastroenterol; 2017 Jun; 23(23):4191-4199. PubMed ID: 28694659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
